Capital Advisors, Ltd. LLC Amgen Inc Transaction History

Capital Advisors, Ltd. LLC

$806 Million
Q3 2024

A detailed history of Capital Advisors, Ltd. LLC transactions in Amgen Inc stock. As of the latest transaction made, Capital Advisors, Ltd. LLC holds 2,180 shares of AMGN stock, worth $576,588. This represents 0.09% of its overall portfolio holdings.

Number of Shares

2,180

Previous 2,175 0.23%

Holding current value

$576,588

Previous $680,000 3.24%

% of portfolio

0.09%

Previous 0.09%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$309.38 - $337.38 $1,546 - $1,686	5 Added 0.23%	2,180 $702,000
Q2 2024 Jul 25, 2024	BUY	$262.75 - $319.31 $20,231 - $24,586	77 Added 3.67%	2,175 $680,000
Q1 2024 Apr 18, 2024	BUY	$268.87 - $324.56 $4,839 - $5,842	18 Added 0.87%	2,098 $597,000
Q4 2023 Feb 02, 2024	BUY	$255.7 - $288.46 $767 - $865	3 Added 0.14%	2,080 $599,000
Q3 2023 Oct 27, 2023	BUY	$218.65 - $271.46 $12,025 - $14,930	55 Added 2.72%	2,077 $558,000
Q2 2023 Jul 26, 2023	BUY	$214.27 - $253.37 $48,210 - $57,008	225 Added 12.52%	2,022 $449,000
Q1 2023 May 03, 2023	SELL	$225.79 - $275.2 $36,803 - $44,857	-163 Reduced 8.32%	1,797 $434,000
Q4 2022 Feb 07, 2023	SELL	$229.03 - $291.01 $124,592 - $158,309	-544 Reduced 21.73%	1,960 $451,000
Q3 2022 Nov 09, 2022	SELL	$224.46 - $253.15 $3,366 - $3,797	-15 Reduced 0.6%	2,504 $564,000
Q2 2022 Aug 05, 2022	BUY	$230.71 - $256.74 $4,383 - $4,878	19 Added 0.76%	2,519 $613,000
Q1 2022 May 09, 2022	BUY	$219.27 - $242.57 $1,096 - $1,212	5 Added 0.2%	2,500 $605,000
Q4 2021 Feb 08, 2022	SELL	$198.88 - $227.6 $34,804 - $39,830	-175 Reduced 6.55%	2,495 $561,000
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $66,440 - $77,843	313 Added 13.28%	2,670 $568,000
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $187,798 - $208,348	804 Added 51.77%	2,357 $575,000
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $1,109 - $1,293	5 Added 0.32%	1,553 $386,000
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $865 - $1,030	4 Added 0.26%	1,548 $356,000
Q3 2020 Nov 03, 2020	BUY	$234.65 - $260.95 $938 - $1,043	4 Added 0.26%	1,544 $392,000
Q2 2020 Aug 06, 2020	SELL	$197.81 - $242.74 $91,586 - $112,388	-463 Reduced 23.12%	1,540 $363,000
Q1 2020 May 08, 2020	BUY	$182.24 - $241.7 $1,457 - $1,933	8 Added 0.4%	2,003 $406,000
Q4 2019 Feb 03, 2020	BUY	$189.21 - $243.2 $1,135 - $1,459	6 Added 0.3%	1,995 $481,000
Q3 2019 Oct 23, 2019	BUY	$174.11 - $208.62 $1,392 - $1,668	8 Added 0.4%	1,989 $385,000
Q2 2019 Jul 31, 2019	BUY	$166.7 - $195.41 $15,169 - $17,782	91 Added 4.81%	1,981 $365,000
Q4 2018 Jan 29, 2019	BUY	$178.4 - $208.25 $1,248 - $1,457	7 Added 0.37%	1,890 $368,000
Q3 2018 Oct 24, 2018	BUY	$185.29 - $208.89 $139,523 - $157,294	753 Added 66.64%	1,883 $390,000
Q2 2018 Jul 20, 2018	BUY	$166.05 - $186.51 $1,328 - $1,492	8 Added 0.71%	1,130 $209,000
Q1 2018 Apr 23, 2018	BUY	$169.43 - $198.0 $1,186 - $1,386	7 Added 0.63%	1,122 $191,000
Q4 2017 Jan 16, 2018	BUY	$168.79 - $188.59 $1,012 - $1,131	6 Added 0.54%	1,115 $194,000
Q3 2017 Oct 25, 2017	BUY	$167.29 - $191.0 $185,524 - $211,819	1,109	1,109 $207,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors, Ltd. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors, Ltd. LLC with notifications on news.

Account

Capital Advisors, Ltd. LLC Amgen Inc Transaction History